Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Alum-ALM + BCG Vaccine for Cutaneous Leishmaniasis in LST+ Volunteers
NCT00429780Phase 3Completed
- Sponsor
- Tehran University of Medical Sciences
- Start
- Jan 2007
- Primary completion
- Sep 2007
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
A Phase 3 trial of alum + autoclaved Leishmania major in cutaneous leishmaniasis (CL), sponsored by Tehran University of Medical Sciences. Started Jan 2007; status: completed.
02
Drugs
alum + autoclaved Leishmania major
03
Conditions
cutaneous leishmaniasis (CL)
Beyond the preview
Go deeper on NCT00429780.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00429780.